Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Drug Benefit Could Make Post-Marketing Studies Faster, Cheaper

Executive Summary

The Centers for Medicare & Medicaid Services expects data on drug use captured through the Medicare Part D benefit to change the way post-marketing studies are performed

You may also be interested in...



PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions

The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians

PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions

The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians

Medicare Rx Data May Be Difficult To Interpret, Merck Exec Cautions

Drawing conclusions about drug safety and outcomes from Medicare prescription drug data needs to be done with caution, Merck VP-Outcomes Research & Management Marc Berger told a Centers for Medicare & Medicaid Services "Open Door Forum" June 13

Related Content

Topics

UsernamePublicRestriction

Register

LL016789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel